Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Market Commentary — 7970 total
Short sellers have been busy in the past seven days. Three names stand out for big moves in the latest ORTEX data through August 27. CAPR — Capricor Therapeutics — saw the sharpest weekly jump. Short interest as a % of…
Federal Reserve Governor Kevin Warsh rattled markets Thursday. His comments revived rate hike bets and sent the Nasdaq 100 lower. Strategy Inc fell more than 7% as Bitcoin pulled back sharply. Coinbase and Affirm were…
Hundreds of companies report this week. Today alone brings a wave of major names across Asia, Europe, and North America. BYD — the world's largest electric vehicle maker — releases results today. The Chinese auto giant…
Workday dominated analyst activity Thursday, with three firms raising price targets after strong earnings. Barclays lifted its target to $224 from $200. Citigroup moved to $201 from $139. Stifel went to $160 from $115.…
Bill Gates has been quietly building a massive position in RSG. Filings show he bought over $561M in Republic Services shares across 44 transactions this month. He paid an average of roughly $218 per share. The buying…
Short sellers made bold moves this week. Capricor Therapeutics saw the biggest jump. Its short interest hit 45.6% of free float — up 9.2 percentage points in just seven days. That is a sharp, sudden build from bears…
Institutional money made a sharp turn this week. The US — the world's largest ETF market — saw a net outflow of $24.2B over the past seven days. That reverses a 3-month trend where US-focused funds pulled in $357.5B.…
PYPL dropped sharply today after reports emerged that Advent International and Stripe abandoned their joint $50 billion takeover bid. The deal collapse removes a key near-term catalyst for the payments giant. Short…
Over 400 companies report this week. The calendar is busiest today, Friday August 28, with key names crossing multiple regions. BeOne Medicines AG headlines today's US-listed action. The $42.7 billion oncology firm…
WDAY took the sharpest blow Thursday. The consensus rating slipped to a downgrade. One analyst cut their hold count. Needham's Scott Berg went the other way, raising his target sharply to $230 from $180 — a $50 jump…
Board members at ILMN have filed a wave of sell orders worth over $200 million in August. Keith Meister and his firm Corvex Management filed multiple tranches of sales this week alone. Meister filed $33M in sales on…
Short sellers are making big moves this week. Data as of August 27 shows sharp shifts in both directions across US markets. CAPR tops the week's biggest short interest builds. Capricor Therapeutics saw its SI % of free…
All eyes are on Kevin Warsh today. The Fed chair speaks at Jackson Hole this morning. S&P 500 and Nasdaq 100 futures are dipping ahead of the address. Markets want signals on the rate path. Any hawkish tone could…
Analysts lifted targets across retail, tech, and industrials this week. The moves follow a busy round of quarterly results. Ulta Beauty drew one of the biggest upgrades. The consensus target rose to $624.50 from…
Board members at ILMN have been filing heavy sell orders. Keith Meister and Corvex Management unloaded a combined $293M in Illumina shares. The filings hit August 6 and August 21. Both sellers sit on the board as asset…
Short sellers made bold moves this week. KVYO saw one of the sharpest increases among mid-cap names. SI % FF jumped from 13.2% to 20.0% in just seven days — a +6.8 percentage point swing. That's a big bet against the…
The dominant story this week is a sharp rotation out of US equities and into fixed income, commodities, and international markets. The US geography bucket logged a $24.2B net outflow over the past week, with a flow…
Bill Gates dominated insider headlines this week. He filed purchases of $562 million in RSG stock between August 10 and August 25. Republic Services is a slow-and-steady waste management play — exactly the kind of…
Nearly 450 US/Canada companies and over 550 European firms report this week. It is one of the busiest end-of-summer stretches on record. BeOne Medicines kicks off today with its latest results. The $42 billion oncology…
Analysts delivered a wave of upward target price revisions Thursday. The sharpest single-analyst move came from Barclays, which raised its target on ABNB from $125 to $150. The bank kept its Hold rating but the 20%…
